Issue of Options
RNS & Investor News
2024
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2023
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2022
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2021
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2020
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2019
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2018
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2017
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2016
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2015
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2014
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
2013
Change of name to OptiBiotix Health Plc
04 August 2014
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
For further information, please contact:
| Ducat Ventures plc Adam Reynolds, Executive Chairman |
www.ducatventures.co.uk Contact via Walbrook below |
| Cairn Financial Advisers LLP Liam Murray / Avi Robinson |
+44 (0)20 7148 7900 |
| Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey |
Tel: 020 7469 0936 |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus Anna Dunphy |
Mob: 07980 541 893 Mob: 07876 741 001 |
Latest RNS News
Latest Video
ProBiotix Health anticipating "big commercial opportunities" during 2023
Group CEO Stephen O’Hara and CEO Steen Anderson | 04 January 2023
www.proactiveinvestors.co.uk
Latest Podcast
Stephen OHara interview with Investors Champion
Stephen O'Hara | 04 Jul 2019
www.investorschampion.com